Zika Virus Vaccines

The Zika virus-caused disease is targeted by the Live-Attenuated antibody. The monovalent antibody form is intended to protect against Zika virus contamination. The Aedes mosquito is the primary carrier of the Genus Flavivirus, which includes the Zika Virus. Understanding the structure of the flavivirus molecule, the significance of E dimers as the primary antigenic target, and a thorough understanding of balance instruments all contribute to the development of the vaccination.

  • Meningococcal

  •  Pneumonia Vaccines

    Related Conference of Zika Virus Vaccines

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    Zika Virus Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in